Loading...

World-Class Retina Care. Community-Based Caring.

Dr. Kothari Featured in New Retina Radio Podcast

Posted On August 5, 2024 / By / Posted in Blog

Dr. Kothari Featured in New Retina Radio Podcast

The New Retina Radio Journal Club and Vit-Buckle Society recently released a podcast featuring Texas Retina’s Nikisha Kothari, MD. In it, she discusses recent research findings from the Diabetic Retinopathy Clinical Research

read more
Posted On August 2, 2024 / By / Posted in Blog

Dr. Abbey First in the World to Administer Novel Trispecific Fusion Antibody EB-105 for Diabetic Macular Edema as Part of Phase Ib LOTUS Clinical Trial

On July 9, Texas Retina Associates Director of Clinical Research for Dallas Ashkan Abbey, MD, dosed the first patient in the Phase Ib LOTUS trial of EB-105, the world’s first pentavalent trispecific

read more
Posted On November 6, 2023 / By / Posted in Blog

Control Your Diabetes to Protect Your Vision

November is National Diabetes Month. Diabetes is a disease that occurs when your blood sugar, also known as blood glucose, is too high. It damages blood vessels all over the body, including

read more
Posted On October 18, 2023 / By / Posted in Blog

New Treatment for Wet AMD and Diabetic Eye Disease Reduces Treatment Burden for Patients by Extending Dosing Intervals

On August 18, 2023, the U.S. Food and Drug Administration (FDA) approved Eylea HD (aflibercept), a high-dose version of Eylea, for the treatment of several retinal conditions, including advanced neovascular age-related macular

read more
Posted On February 28, 2023 / By / Posted in Blog

Four New Clinical Trials Available at Texas Retina Associates

Our physicians remain committed to participating in ongoing retina research and providing our patients access to promising new treatment options through clinical trials. We recently opened four new clinical trials: Diabetic Macular

read more
Posted On September 21, 2022 / By / Posted in Blog

Dr. Abbey Presented National Webinar on Treatment of Patients with Diabetic Macular Edema and 20/50 or Worse Vision

On Monday, September 19, 2022, Texas Retina Associates’ Ashkan M. Abbey, MD, delivered a webinar titled, “Does Treatment Selection Matter in Patients with Diabetic Macular Edema and 20/50 or Worse Vision?” Dr. Abbey discussed

read more
Posted On June 1, 2022 / By / Posted in Blog

Dr. Abbey Presented Preliminary Findings of a Diabetic Macular Edema Clinical Trial at the Retina World Congress

Texas Retina Associates’ Ashkan M. Abbey, MD served as an invited faculty member for the Retina World Congress held May 12-15, 2022, in Fort Lauderdale, Florida. This global physician meeting featured presentations

read more
Posted On November 15, 2021 / By / Posted in Blog

Dr. Abbey Discusses COED Clinical Trial for Diabetic Macular Edema in New Video

In a new video published on Modern Retina, Texas Retina Associates’ Ashkan M. Abbey, MD, discusses the COED clinical trial which is testing the efficacy of combining steroid and anti-VEGF therapy in

read more
Posted On October 12, 2021 / By / Posted in Blog

Dr. Kothari and Dr. Abbey Earn “Top 10 Poster Award” at American Society of Retina Specialists 2021 Annual Scientific Meeting

A research poster by Texas Retina Associates physicians Nikisha Kothari, MD, and Ashkan M. Abbey, MD, was awarded “Top 10” honors at the American Society of Retina Specialists (ASRS) 2021 Annual Scientific

read more
Posted On November 18, 2020 / By / Posted in Blog

New Clinical Trials Enrolling in Plano

At Texas Retina Associates, we remain committed to examining new options that are ethical, based on a solid science platform and provide minimal risks to our patients. Our Plano research team is

read more